St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov attends the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401702
A view shows the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401701
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401699
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401697
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401692
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401691
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401689
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401688
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401685
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401684
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401682
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401680
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401678
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401673
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401672
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401670
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401669
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401667
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401666
An employee works at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401663
Employees work at the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401662
St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov and President of the Pharmasyntez group of companies Vikram Punia, visits the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401652
St. Petersburg Governor Alexander Beglov visits the Pharmasyntez-Nord plant in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401646
St. Petersburg Governor Alexander Beglov visits the Pharmasyntez-Nord plant in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401644
St. Petersburg Governor Alexander Beglov, accompanied by Director General of the Pharmasyntez Nord company Mikhail Kvasnikov and President of the Pharmasyntez group of companies Vikram Punia, visits the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401639
Director General of the Pharmasyntez-Nord Mikahil Kvasnikov and St. Petersburg Governor Alexander Beglov attend he opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401531
Director General of the Pharmasyntez-Nord Mikahil Kvasnikov and St. Petersburg Governor Alexander Beglov shake hands during the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401530
President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the plant, in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401517
Director General of the Pharmasyntez Nord company Mikhail Kvasnikov, President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov attend the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401514
President of the Pharmasyntez group of companies Vikram Punia and St. Petersburg Governor Alexander Beglov shake hands during the opening ceremony of the second stage of the Pharmasyntez-Nord plant, in St. Petersburg, Russia. The second stage of the plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401510
A man talks on the mobile phone at Pharmasyntez Nord plant before the opening ceremony of its second stage in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401464
A man is seen at Pharmasyntez Nord plant before the opening ceremony of its second stage in St. Petersburg, Russia. The second stage of the Pharmasyntez-Nord plant will increase the production of biotechnological pharmaceutical substances and drugs for oncological and autoimmune diseases in humans, as well as genetically engineered insulins and the Sputnik Light Covid-19 vaccine.30.03.2023#8401463
